| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 890.00M | 832.00M | 824.00M | 791.00M | 679.00M | 635.00M |
| Gross Profit | 533.00M | 510.00M | 500.00M | 412.00M | 372.00M | 416.00M |
| EBITDA | 437.00M | 511.00M | -233.00M | -527.00M | 388.00M | -1.31B |
| Net Income | 249.00M | 396.00M | -319.00M | -619.00M | 869.00M | -1.39B |
Balance Sheet | ||||||
| Total Assets | 11.58B | 11.62B | 10.66B | 10.97B | 12.89B | 10.99B |
| Cash, Cash Equivalents and Short-Term Investments | 110.00M | 39.00M | 78.00M | 41.00M | 146.00M | 5.00M |
| Total Debt | 4.65B | 4.55B | 3.78B | 3.54B | 4.55B | 3.52B |
| Total Liabilities | 5.15B | 5.09B | 4.22B | 3.89B | 4.90B | 3.78B |
| Stockholders Equity | 6.43B | 6.51B | 6.40B | 7.00B | 7.92B | 7.21B |
Cash Flow | ||||||
| Free Cash Flow | 182.00M | 93.00M | 212.00M | 240.00M | 339.00M | 15.00M |
| Operating Cash Flow | 182.00M | 256.00M | 338.00M | 342.00M | 381.00M | 233.00M |
| Investing Cash Flow | -363.00M | -383.00M | -272.00M | 834.00M | -607.00M | 334.00M |
| Financing Cash Flow | 234.00M | 88.00M | -29.00M | -1.28B | 362.00M | -1.91B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | £4.49B | 7.70 | 7.16% | 6.67% | 43.70% | 40.28% | |
75 Outperform | £3.81B | 3.98 | 7.75% | 5.85% | -20.83% | ― | |
73 Outperform | £4.36B | 11.16 | 3.85% | 6.34% | 10.69% | 135.58% | |
72 Outperform | £420.67M | 3.34 | 11.57% | 7.17% | 1.60% | 211.81% | |
67 Neutral | £241.38M | 5.97 | 9.81% | 6.64% | ― | ― | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
60 Neutral | £409.59M | 6.81 | 7.51% | 5.15% | -3.98% | 412.08% |